These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11004140)

  • 21. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
    Waters D; Lespérance J; Francetich M; Causey D; Théroux P; Chiang YK; Hudon G; Lemarbre L; Reitman M; Joyal M
    Circulation; 1990 Dec; 82(6):1940-53. PubMed ID: 2242520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden.
    Doyle JJ; McGuire A; Arocho R; Arikian S; Casciano J; Svangren P; Casciano R; Kim R; Kugel H
    Int J Clin Pract; 2002 Mar; 56(2):76-81. PubMed ID: 11926709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.
    Waters D; Lespérance J; Gladstone P; Boccuzzi SJ; Cook T; Hudgin R; Krip G; Higginson L
    Circulation; 1996 Aug; 94(4):614-21. PubMed ID: 8772679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
    Bestehorn HP; Neumann FJ; Büttner HJ; Betz P; Stürzenhofecker P; von Hodenberg E; Verdun A; Levai L; Monassier JP; Roskamm H
    J Am Coll Cardiol; 2004 Jun; 43(12):2160-5. PubMed ID: 15193674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine PREVENTS angina, not atherosclerosis.
    Williams C
    Pharmacotherapy; 2002 Mar; 22(3):400-1; discussion 401-2. PubMed ID: 11898898
    [No Abstract]   [Full Text] [Related]  

  • 30. Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?
    Doggrell SA
    Expert Opin Pharmacother; 2005 May; 6(5):831-4. PubMed ID: 15934908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events].
    Eleuteri E
    Ital Heart J Suppl; 2001 Jan; 2(1):85-6. PubMed ID: 11216089
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
    Packer M; O'Connor CM; Ghali JK; Pressler ML; Carson PE; Belkin RN; Miller AB; Neuberg GW; Frid D; Wertheimer JH; Cropp AB; DeMets DL
    N Engl J Med; 1996 Oct; 335(15):1107-14. PubMed ID: 8813041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic efficiency of amlodipine in the treatment of coronary atherosclerosis--an analysis based on the PREVENT study.
    Cathomas G; Erne P; Schwenkglenks M; Szucs TD
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):61-6. PubMed ID: 12085980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A; Sharma MK; Jain A; Goel PK
    Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study).
    Vigen C; Hodis HN; Selzer RH; Mahrer PR; Mack WJ
    Am J Cardiol; 2005 Jun; 95(11):1277-82. PubMed ID: 15904629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).
    Packer M; Carson P; Elkayam U; Konstam MA; Moe G; O'Connor C; Rouleau JL; Schocken D; Anderson SA; DeMets DL;
    JACC Heart Fail; 2013 Aug; 1(4):308-314. PubMed ID: 24621933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.